Healthcare provider profile · identity verified

Shilpa Jog, MD

Internal Medicine · EVERETT, WA · NPI 1154516268

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	768	265
Amlodipine Besylate	Amlodipine Besylate	345	113
Lisinopril	Lisinopril	335	102
Omeprazole	Omeprazole	300	101
Levothyroxine Sodium	Levothyroxine Sodium	293	93
Losartan Potassium	Losartan Potassium	288	102
Gabapentin	Gabapentin	213	78
Metoprolol Succinate	Metoprolol Succinate	199	62
Hydrochlorothiazide	Hydrochlorothiazide	154	52
Trazodone Hcl	Trazodone Hcl	150	50
Atenolol	Atenolol	136	39
Famotidine	Famotidine	128	38
Metformin Hcl Er	Metformin Hcl	117	39
Tizanidine Hcl	Tizanidine Hcl	115	47
Alendronate Sodium	Alendronate Sodium	114	41
Sertraline Hcl	Sertraline Hcl	105	25
Duloxetine Hcl	Duloxetine Hcl	100	35
Rosuvastatin Calcium	Rosuvastatin Calcium	100	39
Albuterol Sulfate Hfa	Albuterol Sulfate	96	58
Metformin Hcl	Metformin Hcl	89	33
Escitalopram Oxalate	Escitalopram Oxalate	86	35
Pantoprazole Sodium	Pantoprazole Sodium	83	29
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	78	18
Furosemide	Furosemide	74	27
Glipizide Er	Glipizide	71	21
Fluoxetine Hcl	Fluoxetine Hcl	70	19
Fluticasone Propionate	Fluticasone Propionate	70	37
Montelukast Sodium	Montelukast Sodium	69	17
Citalopram Hbr	Citalopram Hydrobromide	68	21
Metoprolol Tartrate	Metoprolol Tartrate	66	20
Potassium Chloride	Potassium Chloride	64	32
Simvastatin	Simvastatin	63	24
Venlafaxine Hcl Er	Venlafaxine Hcl	57	19
Buspirone Hcl	Buspirone Hcl	54	19
Tamsulosin Hcl	Tamsulosin Hcl	52	23
Eliquis	Apixaban	51	18
Pravastatin Sodium	Pravastatin Sodium	51	19
Carvedilol	Carvedilol	45	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	18
Zolpidem Tartrate	Zolpidem Tartrate	45	13
Clonazepam	Clonazepam	44	suppressed
Mirtazapine	Mirtazapine	44	17
Tramadol Hcl	Tramadol Hcl	44	12
Bupropion Xl	Bupropion Hcl	42	16
Ozempic	Semaglutide	42	suppressed
Trulicity	Dulaglutide	41	13
Diclofenac Sodium	Diclofenac Sodium	40	17
Methocarbamol	Methocarbamol	40	13
Allopurinol	Allopurinol	35	14
Alprazolam	Alprazolam	35	14
Estradiol	Estradiol	35	11
Jardiance	Empagliflozin	34	17
Lorazepam	Lorazepam	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	24
Ondansetron Odt	Ondansetron	31	11
Clopidogrel	Clopidogrel Bisulfate	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	suppressed
Fenofibrate	Fenofibrate	30	suppressed
Ezetimibe	Ezetimibe	29	11
Lovastatin	Lovastatin	29	11
Topiramate	Topiramate	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	15
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Pregabalin	Pregabalin	25	13
Benazepril Hcl	Benazepril Hcl	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Varenicline Tartrate	Varenicline Tartrate	24	suppressed
Ibuprofen	Ibuprofen	23	11
Temazepam	Temazepam	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Acyclovir	Acyclovir	20	13
Incruse Ellipta	Umeclidinium Bromide	20	suppressed
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Gemfibrozil	Gemfibrozil	18	suppressed
Nystatin	Nystatin	18	suppressed
Mupirocin	Mupirocin	17	11
Valacyclovir	Valacyclovir Hcl	17	suppressed
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	16	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Finasteride	Finasteride	15	suppressed
Lactulose	Lactulose	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Azithromycin	Azithromycin	14	13
Baclofen	Baclofen	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Glipizide	Glipizide	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Prednisone	Prednisone	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error